Sector Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 232.51 USD | -0.90% |
|
+2.62% | +16.56% |
| 07-29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.90% | +2.62% | +2.52% | +39.25% | +16.56% | +37.06% | +10.96% | -42.86% | +164.43% | 11.3B | |
| -1.40% | +2.59% | +3.00% | +17.32% | +4.54% | -1.71% | +11.28% | -20.28% | +207.72% | 49.37B | |
| -2.41% | -0.90% | +0.13% | +30.12% | +135.44% | +403.17% | +614.40% | +554.78% | - | 40.85B | |
| -1.16% | +12.96% | +21.63% | +48.40% | +4.26% | +26.45% | +5.03% | -5.12% | +202.70% | 39.14B | |
| -1.88% | -3.03% | +10.89% | +7.02% | +4.02% | +4.94% | +47.52% | -0.18% | +1,104.31% | 35.81B | |
| -1.74% | +5.12% | +7.73% | -2.23% | +8.31% | +9.58% | +46.02% | -10.42% | +155.22% | 30.5B | |
| -2.85% | -3.92% | -8.55% | +6.33% | - | - | - | - | - | 16.55B | |
| -0.21% | -4.04% | +8.97% | +37.85% | +2.75% | +35.09% | +127.95% | +228.02% | - | 16.14B | |
| -0.64% | +2.65% | -0.58% | +15.49% | +9.23% | +1.25% | +8.92% | -32.41% | +103.19% | 13.71B | |
| -1.19% | -1.32% | -5.84% | +38.23% | -10.24% | -3.32% | -34.94% | -32.76% | +110.59% | 12.77B | |
| +0.08% | +0.68% | +2.04% | +30.31% | +22.58% | +31.72% | -13.56% | -40.20% | +156.50% | 11.22B | |
| -2.03% | -5.76% | -7.97% | +10.21% | -11.71% | +66.09% | +506.74% | +253.74% | +2,461.45% | 10.77B | |
| -0.16% | -0.14% | +1.02% | +61.77% | +77.65% | +250.47% | +526.59% | - | - | 10.08B | |
| -1.44% | +0.39% | +11.47% | +38.06% | +56.45% | +153.69% | +604.33% | +176.43% | - | 8.92B | |
| +2.19% | -4.49% | +27.20% | +25.55% | +29.44% | +18.33% | +30.04% | -58.18% | - | 8.9B | |
| -2.83% | -8.45% | -34.71% | -30.75% | -34.56% | +20.45% | +24.96% | +39.39% | +77.36% | 8.85B | |
| -3.37% | -6.48% | -9.83% | +27.54% | +32.89% | +136.34% | +372.58% | +71.82% | - | 8.8B | |
| +0.03% | -5.37% | -8.05% | -3.45% | +4.44% | +467.74% | +1,972.72% | +31.55% | - | 8.58B | |
| -0.12% | +0.07% | +5.88% | +19.72% | -12.54% | -20.29% | -20.78% | -29.74% | +33.27% | 8.57B | |
| -2.08% | -7.37% | -6.50% | +45.33% | +75.09% | +84.94% | +67.32% | +89.37% | -1.82% | 8.39B | |
| Average | -1.21% | -0.86% | +1.02% | +23.10% | +21.82% | +90.63% | +258.32% | +65.16% | +397.91% | 17.96B | |
| Weighted average by Cap. | -1.41% | +1.44% | +3.90% | +22.70% | +25.59% | +87.28% | +198.16% | +85.85% | +400.83% |
- Stock Market
- Stocks
- CRL Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
